Koenig Sheldon L. 4
4 · Esperion Therapeutics, Inc. · Filed Mar 15, 2023
Insider Transaction Report
Form 4
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
- Award
Common Stock
2023-03-14+105,000→ 299,815 total - Award
Stock Option (right to buy)
2023-03-14+445,000→ 445,000 totalExercise: $4.02Exp: 2033-03-14→ Common Stock (445,000 underlying)
Footnotes (2)
- [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which shall be on June 15, 2023, subject to continued service.
- [F2]Such options will vest over a four (4) year period in equal quarterly installments, the first of which shall be on June 15, 2023, subject to continued service.